Core Scientific Inc vs Coupang Inc — how do they compare? Core Scientific Inc trades at $15.46 (market cap $4.94B), while Coupang Inc trades at $15.83 (market cap $27.70B). The key difference: Coupang Inc is far larger — about 5.6× Core Scientific Inc's market cap, and Coupang Inc is more actively traded (27,703,608 versus 15,630,800). Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Coupang Inc for 55 Days on average.
| CORZ | CPNG | |
|---|---|---|
Market Cap | $4.94B | $27.70B |
Volume | 15,630,800 | 27,703,608 |
Sector | Technology | Consumer Cyclical |
52-Week High | $29.16 | $32.47 |
52-Week Low | $13.57 | $13.75 |
Typical Hold Time | 20 Days | 55 Days |
Enterprise Value | $7.46B | $27.22B |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.30, down 4.02% today amid bearish technical signals and negative earnings momentum. The stock faces fundamental challenges with a net income margin of -324.9% and three consecutive quarterly earnings misses. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.75 consensus price target, while recent executive appointments and AI infrastructure developments provide potential catalysts.
Despite current financial struggles, CORZ shows potential through its pivot to AI data center services and strong institutional support. Key risks include persistent negative profitability, high capital expenditures, and cryptocurrency market volatility. The significant gap between current price and analyst targets suggests upside potential if the company executes its AI infrastructure strategy successfully.
Coupang (CPNG) trades at $15.82, up 6.82% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical outlook with positive moving averages and institutional support. Revenue growth remains robust at $34.53 billion for 2025, though profitability metrics show challenges with negative net income margin and ROE. Analyst consensus is strongly bullish with 87.5% buy ratings and a $25.25 price target, representing significant upside potential from current levels.
The investment case hinges on Coupang's dominant South Korean market position and expanding logistics network, but faces headwinds from inconsistent profitability and competitive pressures. While valuation appears reasonable on sales (P/S 0.8), high P/E ratio reflects earnings volatility. Key risks include execution challenges in international expansion and margin pressure from logistics investments. The stock offers growth exposure but requires careful monitoring of profitability trends.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.
Read more on CPNG →